These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36496282)

  • 1. A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales.
    Serisier A; Beale S; Boukari Y; Hoskins S; Nguyen V; Byrne T; Fong WLE; Fragaszy E; Geismar C; Kovar J; Yavlinsky A; Hayward A; Aldridge RW
    Vaccine; 2023 Jan; 41(2):511-518. PubMed ID: 36496282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking Changes in Mobility Before and After the First SARS-CoV-2 Vaccination Using Global Positioning System Data in England and Wales (Virus Watch): Prospective Observational Community Cohort Study.
    Nguyen V; Liu Y; Mumford R; Flanagan B; Patel P; Braithwaite I; Shrotri M; Byrne T; Beale S; Aryee A; Fong WLE; Fragaszy E; Geismar C; Navaratnam AMD; Hardelid P; Kovar J; Pope A; Cheng T; Hayward A; Aldridge R;
    JMIR Public Health Surveill; 2023 Mar; 9():e38072. PubMed ID: 36884272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
    Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
    Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Second Dose of SARS-CoV-2 Vaccination on Household Transmission, England.
    Zaidi A; Harris R; Hall J; Woodhall S; Andrews N; Dunbar K; Lopez-Bernal J; Dabrera G
    Emerg Infect Dis; 2023 Jan; 29(1):127-132. PubMed ID: 36529456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study.
    Davies NG; Barnard RC; Jarvis CI; Russell TW; Semple MG; Jit M; Edmunds WJ; ;
    Lancet Infect Dis; 2021 Apr; 21(4):482-492. PubMed ID: 33357518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprivation and exposure to public activities during the COVID-19 pandemic in England and Wales.
    Beale S; Braithwaite I; Navaratnam AM; Hardelid P; Rodger A; Aryee A; Byrne TE; Fong EWL; Fragaszy E; Geismar C; Kovar J; Nguyen V; Patel P; Shrotri M; Aldridge R; Hayward A;
    J Epidemiol Community Health; 2022 Apr; 76(4):319-326. PubMed ID: 34642240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
    Kerr S; Joy M; Torabi F; Bedston S; Akbari A; Agrawal U; Beggs J; Bradley D; Chuter A; Docherty AB; Ford D; Hobbs R; Katikireddi SV; Lowthian E; de Lusignan S; Lyons R; Marple J; McCowan C; McGagh D; McMenamin J; Moore E; Murray JK; Owen RK; Pan J; Ritchie L; Shah SA; Shi T; Stock S; Tsang RSM; Vasileiou E; Woolhouse M; Simpson CR; Robertson C; Sheikh A
    PLoS Med; 2022 Feb; 19(2):e1003927. PubMed ID: 35192598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection and vaccination uptake in men and gender-diverse people who have sex with men in the UK: analyses of a large, online community cross-sectional survey (RiiSH-COVID) undertaken November-December 2021.
    Ogaz D; Allen H; Reid D; Brown JRG; Howarth AR; Pulford CV; Mercer CH; Saunders J; Hughes G; Mohammed H
    BMC Public Health; 2023 May; 23(1):829. PubMed ID: 37147609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the effects of SARS-CoV-2 vaccination on the risk of household transmission during delta variant circulation: a population-based data linkage cohort study.
    Vogt F; Rebuli N; Cretikos M; Liu B; Macartney K; Kaldor J; Wood J
    Lancet Reg Health West Pac; 2024 Jan; 42():100930. PubMed ID: 38357393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.
    Chadeau-Hyam M; Wang H; Eales O; Haw D; Bodinier B; Whitaker M; Walters CE; Ainslie KEC; Atchison C; Fronterre C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Cooke G; Ward H; Darzi A; Riley S; Donnelly CA; Elliott P;
    Lancet Respir Med; 2022 Apr; 10(4):355-366. PubMed ID: 35085490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
    Byrne T; Patel P; Shrotri M; Beale S; Michie S; Butt J; Hawkins N; Hardelid P; Rodger A; Aryee A; Braithwaite I; Fong WLE; Fragaszy E; Geismar C; Kovar J; Navaratnam AMD; Nguyen V; Hayward A; Aldridge RW;
    Vaccine; 2021 Nov; 39(48):7108-7116. PubMed ID: 34728095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
    McCormick DW; Konkle SL; Magleby R; Chakrabarti AK; Cherney B; Lindell K; Namageyo-Funa A; Visser S; Soto RA; Donnelly MAP; Stringer G; Austin B; Beatty ME; Stous S; Albanese BA; Chu VT; Chuey M; Dietrich EA; Drobeniuc J; Folster JM; Killerby ME; Lehman JA; McDonald EC; Ruffin J; Schwartz NG; Sheldon SW; Sleweon S; Thornburg NJ; Hughes LJ; Petway M; Tong S; Whaley MJ; Kirking HL; Tate JE; Hsu CH; Matanock A;
    Vaccine; 2022 Aug; 40(33):4845-4855. PubMed ID: 35803846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.
    Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study.
    Martínez-Baz I; Miqueleiz A; Egüés N; Casado I; Burgui C; Echeverría A; Navascués A; Fernández-Huerta M; García Cenoz M; Trobajo-Sanmartín C; Guevara M; Ezpeleta C; Castilla J
    J Infect Public Health; 2023 Mar; 16(3):410-417. PubMed ID: 36724697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.